Wolfgang A Lilleby (Wolfgang Lilleby, W Lilleby)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 11

Top Topics

Locally Advanced

Prostate Cancer

Radiation Induced

Top Venues

International journal of cancer

Cancer immunology, immunotherapy : CII

Scandinavian journal of urology

This page only lists publications with an associated author ORCID identifier.

Publications

Wolfgang A Lilleby, Therese Seierstad, Else Marit Inderberg, Knut Håkon Hole
Impact of human telomerase reverse transcriptase peptide vaccine combined with androgen deprivation therapy and radiotherapy in de novo metastatic prostate cancer: Long-term clinical monitoring. International journal of cancer (2023)
Wolfgang A Lilleby, Therese Seierstad, Else Marit Inderberg, Knut Håkon Hole
Impact of human telomerase reverse transcriptase peptide vaccine combined with androgen deprivation therapy and radiotherapy in de novo metastatic prostate cancer: Long-term clinical monitoring. International journal of cancer 152 (10) (2023)
Wolfgang A Lilleby, Therese Seierstad, Else Marit Inderberg, Knut Håkon Hole
Impact of human telomerase reverse transcriptase peptide vaccine combined with androgen deprivation therapy and radiotherapy in de novo metastatic prostate cancer: Long-term clinical monitoring. International journal of cancer 152 (10) (2023)
Wolfgang A Lilleby, Therese Seierstad, Else Marit Inderberg, Knut Håkon Hole
Impact of human telomerase reverse transcriptase peptide vaccine combined with androgen deprivation therapy and radiotherapy in de novo metastatic prostate cancer: Long-term clinical monitoring. International journal of cancer 152 (10) (2023)
Wolfgang A Lilleby, Therese Seierstad, Else Marit Inderberg, Knut Håkon Hole
Impact of human telomerase reverse transcriptase peptide vaccine combined with androgen deprivation therapy and radiotherapy in de novo metastatic prostate cancer: Long-term clinical monitoring. International journal of cancer 152 (10) (2023)
Wolfgang A Lilleby, Therese Seierstad, Else Marit Inderberg, Knut Håkon Hole
Impact of human telomerase reverse transcriptase peptide vaccine combined with androgen deprivation therapy and radiotherapy in de novo metastatic prostate cancer: Long-term clinical monitoring. International journal of cancer (2023)
Anne M A Tryggestad, Karol Axcrona, Ulrika Axcrona, Iris Bigalke, Bjørn Brennhovd, Else Marit Inderberg, Turid K Hønnåshagen, Lisbeth J Skoge, Guri Solum, Stein Saebøe-Larssen, Dag Josefsen, Richard W Olaussen, Steinar Aamdal, Rolf I Skotheim, Tor-Åge Myklebust, Dolores J Schendel, Wolfgang A Lilleby, Svein Dueland, Gunnar Kvalheim
Long-term first-in-man Phase I/II study of an adjuvant dendritic cell vaccine in patients with high-risk prostate cancer after radical prostatectomy. The Prostate (2021)
Ting Martin Ma, Oscar Lilleby, Wolfgang A Lilleby, Amar U Kishan
Ablative Radiotherapy in Prostate Cancer: Stereotactic Body Radiotherapy and High Dose Rate Brachytherapy. Cancers 12 (12) (2020)
Matthew Deek, Wolfgang A Lilleby, Victoria Vaage, Knut H Hole, Theodore DeWeese, Andreas Stensvold, Phuoc Tran, Therese Seierstad
Impact of radiation dose on recurrence in high-risk prostate cancer patients. The Prostate 80 (15) (2020)
Johan Stranne, Martin Andreas Røder, B Brennhovd, E Johansson, Fredrik Jäderling, M Kouri, Wolfgang A Lilleby, P Meidahl Petersen, Tuomas K Mirtti, A Pettersson, Antti Sakari Rannikko, Camilla Thellenberg Karlsson, Olof Akre
SPCG-15: a prospective randomized study comparing primary radical prostatectomy and primary radiotherapy plus androgen deprivation therapy for locally advanced prostate cancer. Scandinavian journal of urology 52 (5-6) (2018)
Wolfgang A Lilleby, Gustav Gaudernack, Paal F Brunsvig, Ljiljana Vlatkovic, Melanie Schulz, Kate Mills, Knut Håkon Hole, Else Marit Inderberg
Phase I/IIa clinical trial of a novel hTERT peptide vaccine in men with metastatic hormone-naive prostate cancer. Cancer immunology, immunotherapy : CII 66 (7) (2017)